Table 3.
Multiple comparisons of right hippocampal NAA.
| Group | Mean | SD | p | 95% confidence interval | ||
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | |||||
| DR | T2DM | −7.24610* | 3.06174 | 0.021* | −13.3557 | −1.1365 |
| HC | −13.85166* | 3.06174 | 0.000* | −19.9613 | −7.7421 | |
| T2DM | DR | 7.24610* | 3.06174 | 0.021* | 1.1365 | 13.3557 |
| HC | −6.60556* | 2.69142 | 0.017* | −11.9762 | −1.2349 | |
| HC | DR | 13.85166* | 3.06174 | 0.000* | 7.7421 | 19.9613 |
| T2DM | 6.60556* | 2.69142 | 0.017* | 1.2349 | 11.9762 | |
*
The right hippocampal NAA was compared between any two groups, p <0.05, the difference was statistically significant. T2DM, Type 2 diabetes mellitus; DR, diabetic retinopathy; NAA, Nacetylaspartate.